Using Tenofovir Vaginal Gel for HIV Prevention
What is the impact of using tenofovir vaginal gel on HIV infection rates among sexually active South African women?
a. Using tenofovir vaginal gel before and after intercourse reduced HIV infection by 39%.
b. Using tenofovir vaginal gel only after intercourse reduced HIV infection by 39%.
c. Using tenofovir vaginal gel before intercourse increased the risk of HIV infection by 39%.
d. Using tenofovir vaginal gel had no impact on HIV infection rates for South African women.
Answer:
The use of tenofovir vaginal gel both before and after intercourse has been shown to reduce HIV infection by 39% among sexually active South African women.
The correct statement regarding the use of tenofovir vaginal gel by sexually active South African women and its impact on HIV infection rates is: 'Using tenofovir vaginal gel before and after intercourse reduced HIV infection by 39%'. This indicates that the use of tenofovir vaginal gel both before and after intercourse played a significant role in the reduction of HIV infection among this group of women. This was likely due to the fact that the gel provides a protective barrier that blocks the transmission of the HIV virus. It should also be noted that the gel should be used in conjunction with other forms of protection like condoms, to further reduce the risk.